Cross-Sector entity
Agilent is most often covered alongside Adam Alanoff, which appears in 3 of these 3 stories. The clearest coverage concentration is earnings: 1 of 3 stories, with the rest divided among 2 other categories. Each carries 2 original sources on average.
3 verified stories tracked
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Agilent is most often covered alongside Adam Alanoff, which appears in 3 of these 3 stories. The clearest coverage concentration is earnings: 1 of 3 stories, with the rest divided among 2 other categories. Each carries 2 original sources on average. We currently track 3 Cross-Sector stories that mention Agilent, all published on February 26, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Agilent. Shared-story counts are live from our verified record — not editorial picks.
Agilent reported a resilient first quarter despite weather disruptions and tariff-driven margin pressure, while TJX capped a record fiscal year with $60.4 billion in sales. Both companies highlighted shifting consumer and industrial demand, with Agilent navigating soft academic markets and TJX leveraging inventory flexibility to drive 5% comparable sales growth.
Agilent reported a 4.4% core revenue growth in Q1 2026, driven by a strong 7% uptick in the pharmaceutical sector despite an 8% decline in academic and government markets. The company is navigating margin pressures from new tariffs while leaning into high-growth areas like GLP-1 manufacturing and CDMO services.
Agilent Technologies reported a resilient Q1 2026 with $1.8 billion in revenue, driven by a 7% growth in the pharma sector despite significant headwinds in academic and government funding. While the company faced a 100-basis-point gross margin compression due to rising tariffs and weather disruptions, strong performance in the Agilent CrossLab Group suggests a shift toward service-oriented recurring revenue.
Source: Motley Fool Transcribing (us) · Motley Fool Transcribing (us)
